Páez-Franco, J.C.; Zermeño-Ortega, M.R.; de la O-Contreras, C.M.; Canseco-González, D.; Parra-Unda, J.R.; Avila-Sorrosa, A.; EnrÃquez, R.G.; Germán-Acacio, J.M.; Morales-Morales, D.
Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment. Pharmaceutics 2022, 14, 402.
https://doi.org/10.3390/pharmaceutics14020402
AMA Style
Páez-Franco JC, Zermeño-Ortega MR, de la O-Contreras CM, Canseco-González D, Parra-Unda JR, Avila-Sorrosa A, EnrÃquez RG, Germán-Acacio JM, Morales-Morales D.
Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment. Pharmaceutics. 2022; 14(2):402.
https://doi.org/10.3390/pharmaceutics14020402
Chicago/Turabian Style
Páez-Franco, José C., Miriam R. Zermeño-Ortega, Carmen Myriam de la O-Contreras, Daniel Canseco-González, Jesus R. Parra-Unda, Alcives Avila-Sorrosa, Raúl G. EnrÃquez, Juan M. Germán-Acacio, and David Morales-Morales.
2022. "Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment" Pharmaceutics 14, no. 2: 402.
https://doi.org/10.3390/pharmaceutics14020402
APA Style
Páez-Franco, J. C., Zermeño-Ortega, M. R., de la O-Contreras, C. M., Canseco-González, D., Parra-Unda, J. R., Avila-Sorrosa, A., EnrÃquez, R. G., Germán-Acacio, J. M., & Morales-Morales, D.
(2022). Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment. Pharmaceutics, 14(2), 402.
https://doi.org/10.3390/pharmaceutics14020402